MTSS1 and cancer: In analyses of several public clinical datasets of LUAD46–48, we found that MTSS1 mRNA and protein levels were significantly lower in cancer tissues as compared with normal adjacent tissues (NATs), and MTSS1 downregulation in LUAD was associated with poor patient survival (Fig. 1a and Supplementary Fig. S1a, b).